drugset / Trial / NCT01417754
Changes in Breast 3D Ultrasound Measurements Using Toremifene
Phase 3
Completed
20 enrolled
Satakunta Central Hospital
Tampere University · collabTampere University Hospital · collab
RandomizedSingle-groupOpen-labelDiagnostic
Summary
To investigate if there are detectable changes in volume and circulation in breasts of healthy volunteers using toremifene 20 mg in luteal phase of the menstruation cycle versus nonmedicated cycle.
Timeline
- Start
- 2010-09
- Primary completion
- 2010-11
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Toremifene | Small molecule | 20 mg | — |
Indications
No indication recorded.